Association between THSD4 Gene Polymorphisms and Hepatocellular Carcinoma in Korean Population

다국어 초록 (Multilingual Abstract)

Hepatocellular carcinoma (HCC) is a hypervascular tumor characterized by neovascularization, which plays an important role in the growth and progression of cancer. This study assessed the association of thrombospondin, type I, domain containing 4 (THSD4) polymorphisms with HCC in Korean population. We selected three single nucleotide polymorphisms (SNPs) (rs961577, rs4777350, and rs2062651) in the THSD4 gene (heterozygosity＞0.1). SNP genotyping was conducted using a customized Illumina BeadChip and direct sequencing in 189 HCC patients and 386 control subjects in Korean population. For the analysis of data, EM algorithm, SNPStats, SNPAnalyzer, and Helixtree programs were used. Multiple logistic regression analysis with the codominant, dominant, and recessive models was performed. Statistical analysis revealed that a significant association (rs2062651) was found between HCC and controls. Our genetic result suggests that THSD4 may be associated with the development of HCC. (Cancer Prev Res 13, 81-84, 2008)

참고문헌 (Reference)

1 O'Shea, K.S., "Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo" 107 : 2737-2748, 1988

2 Lawler, J., "Tumor progression: the effects of thrombospondin-1 and -2" 36 : 1038-1045, 2004

3 Stenina, O.I., "Thrombospondins, their polymorphisms, and cardiovascular disease" 27 : 1886-1894, 2007

4 Lawler, J., "Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia" 101 : 982-992, 1998

5 Isenberg, J.S., "Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner" 13141-13146, 2005

6 Lawler, J., "Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth" 6 : 1-12, 2002

7 Tuszynski, G.P., "The role of thrombospondin-1 in tumor progression and angiogenesis" 18 : 71-76, 1996

8 Esemuede, N., "The role of thrombospondin-1 in human disease" 122 : 135-142, 2004

9 Chen, H., "The cell biology of thrombospondin-1" 19 : 597-614, 2000

10 Poon, R.T., "Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study" 233 : 227-235, 2001

11 Roberts, D.D, "Regulation of tumor growth and metastasis by thrombospondin-1" 10 : 1183-1191, 1996

12 Yao, D.F., "Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma" 4 : 220-226, 2005

13 Vogel, T., "Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin" 53 : 74-84, 1993

14 Barrett, J.C., "Haploview: analysis and visualization of LD and haplotype maps" 21 : 263-265, 2005

15 Faul, F., "G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences" 39 : 175-191, 2007

16 Iruela-Arispe, M.L., "Differential expression of thrombospondin 1, 2, and 3 during murine development" 197 : 40-56, 1993

17 Silverstein, R.L., "CD36-TSP-HRGP interactions in the regulation of angiogenesis" 13 : 3559-3567, 2007

18 Sahani, D.V., "Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience" 243 : 736-743, 2007